Showing results (41-50 of 297) with videos related to

Sort By:
Pageof 30
Current Opinion in Nephrology and Hypertension|March 3, 2023
An update on corticosteroid treatment for IgA nephropathyMalak Ghaddar, Jonathan Barratt, Sean J Barbour
Kidney International Reports|February 12, 2024
Novel Treatment Paradigms: Primary IgA NephropathyHaresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
International Journal of Molecular Sciences|June 13, 2018
The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical PerspectiveShalini M Krishnan, Jan R Kraehling, Frank Eitner, et al.
Current Opinion in Nephrology and Hypertension|July 22, 2025
IgA nephropathy: a paradigm shift in treatment strategiesLydia Roberts, Max Jones, Jonathan Barratt, et al.
Journal of Clinical Medicine|June 2, 2021
The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021?Izabella Z A Pawluczyk, Haresh Selvaskandan, Jonathan Barratt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 7, 2023
IgA nephropathy in adults-treatment standardPatrick J Gleeson, Michelle M O'Shaughnessy, Jonathan Barratt
Nephrology (Carlton, Vic.)|April 13, 2019
Is immunoglobulin A nephropathy different in different ethnic populations?See Cheng Yeo, Su Mein Goh, Jonathan Barratt
Drug Design, Development and Therapy|August 5, 2024
Insights on Nefecon®, a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA NephropathyJonathan Barratt, Jens Kristensen, Christian Pedersen, et al.
Pediatric Nephrology (Berlin, Germany)|June 19, 2017
New insights into the pathogenesis of IgA nephropathySee Cheng Yeo, Chee Kay Cheung, Jonathan Barratt
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2020
The Metalloproteinase ADAMTS5 Is Expressed by Interstitial Inflammatory Cells in IgA Nephropathy and Is Proteolytically Active on the Kidney MatrixScott Taylor, Molly Whitfield, Jonathan Barratt, et al.
Pageof 30